🔗 Share this article

A shadow market for unlicensed slimming medications is propelled by social media fitness personalities and sellers on messaging platforms, according to recent findings.

Investigational Drug Acquiring Popularity Online

Retatrutide, which remains in clinical trials, is being promoted by online personalities for its alleged fat-burning effects. Followers are encouraged to message these accounts directly for source information, while also receiving discount codes.

Active Trade on Messaging Platforms

Additionally, a flourishing market exists on messaging services, where groups with thousands of participants share “before and after” photos, injection guides and claims of rapid British shipping. Vendors promote the drug there before directing buyers to other platforms for transactions.

Understanding The Experimental Drug

This medication is an experimental injection created by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies suggest it could assist patients lose up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being promoted online as the next Ozempic.

Healthcare Professionals Express Worries

Nevertheless, doctors and pharmacists have warned that the distribution of what remains an unlicensed medication in the UK is worrisome and could result in users administering substances of uncertain source.

Some experts stated the demand for retatrutide could be linked to the rising price of approved slimming products such as Mounjaro.

Legal Status and Implementation

Selling the unapproved drug on social media or messaging apps is illegal in the UK, as it is an unlicensed drug that cannot be promoted or supplied for personal consumption under the British medical regulations.

Several influencers attempt to circumvent the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but promotion and supply can still violate pharmaceutical, advertising, and customer laws, potentially leading to penalties, legal action or prison.

Service Reaction and Content Elimination

According to TikTok, the platform has removed problematic content and prohibited related keywords and query recommendations. The organization said it was dedicated to maintaining the service secure and allocating resources in enhancing enforcement strategies.

Online Trading Operations

Research also discovered groups with up to nine thousand members selling retatrutide using Telegram's built-in search feature, which operates like a online catalog. Typing “retatrutide” immediately displays groups with numerous of users, filled with images of weight loss, positive reviews and detailed instructions for mixing or injecting at home.

Within minutes of entering one group, a vendor shared contact information, where most purchases take place. The vendor provided an instruction manual and promised shipping within 48 hours. When asked whether the product was authentic, one seller said: “You can’t be sure.” Another shared a image of a supposed testing documentation. None asked about weight, health issues or past usage.

Product Details and Costs

Inside these communities, messages display black plastic parcels with Royal Mail labels, stating to contain new batches. One communication stated: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, mixed at home with sterile water, or ready-to-use pens usually priced at 160 pounds for 20mg. When questioned how long a pen should be used, sellers give conflicting answers ranging from a few weeks to “depends on your body”.

Platform Oversight and Security Actions

A representative for Telegram said it regularly moderated dangerous content on its service including material that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Warnings

“Individuals are administering materials they cannot confirm. Although the research behind this drug is sound, these digital products may not contain what they claim,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in interest to recent cost increases for approved slimming medications such as Mounjaro. “With costs rising, patients are using online platforms. But counterfeit injections are extremely dangerous. You can’t be certain what’s inside or whether the conditions they were made in was sterile,” she explained.

Her team has previously encountered individuals injured by personal administration from unconfirmed suppliers. “We understand the disappointment, but buying from Telegram or communication platforms is gambling with your well-being,” stated Wyllie. “These substances could be impure or improperly measured.”

Manufacturer Statement

A representative from the pharmaceutical company stated the substance was in third stage clinical trials and had not been evaluated or authorized by any regulatory agency globally. “Therefore at this time no one can market [it] for human use,” they explained, adding that any product “falsely representing itself as a Lilly experimental product not yet approved … may expose patients to potentially serious health risks”.